Vineet Laboratories Limited — Investor Relations & Filings
Vineet Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and API intermediates. The company focuses on producing high-quality chemical compounds through advanced research and development, catering to diverse therapeutic segments including anti-retroviral, anti-diabetic, and anti-hypertensive treatments. Its core operations involve the synthesis of complex molecules and fine chemicals, supported by manufacturing facilities that adhere to rigorous quality management systems. Vineet Laboratories provides custom synthesis and contract manufacturing services, positioning itself as a technical partner for global healthcare organizations. The company emphasizes process optimization and cost-effective production to deliver reliable chemical solutions for large-scale pharmaceutical applications.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2023-04-06 | English | |
| Trading Window | 2023-03-30 | English | |
| Reply to Clarification- Financial results | 2023-02-28 | English | |
| Copy of Newspaper Publication | 2023-02-15 | English | |
| Financial Result Updates | 2023-02-15 | English | |
| Outcome of Board Meeting | 2023-02-14 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
8 filings
| |||||
| 42840541 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2023-04-06 | English | ||
| 42838670 | Trading Window | 2023-03-30 | English | ||
| 42881751 | Reply to Clarification- Financial results | 2023-02-28 | English | ||
| 42890939 | Copy of Newspaper Publication | 2023-02-15 | English | ||
| 42892473 | Financial Result Updates | 2023-02-15 | English | ||
| 42917592 | Outcome of Board Meeting | 2023-02-14 | English | ||
| 42942867 | Board Meeting Intimation | 2023-02-07 | English | ||
| 42895665 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2023-01-04 | English | ||
|
2022
7 filings
| |||||
| 42920699 | Trading Window | 2022-12-30 | English | ||
| 42924552 | Related Party Transaction | 2022-11-29 | English | ||
| 42919796 | Newspaper Advertisements | 2022-11-16 | English | ||
| 42963161 | Outcome of Board Meeting | 2022-11-14 | English | ||
| 44004338 | Board Meeting — Financial results | 2022-11-07 | English | ||
| 42935837 | General updates | 2022-10-13 | English | ||
| 42967841 | Annual General Meeting | 2022-09-30 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Vineet Laboratories Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61522/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61522 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61522 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61522 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61522}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Vineet Laboratories Limited (id: 61522)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.